相关实验视频
Updated: Jun 22, 2025

08:09
Vessel-sparing Excision and Primary Anastomosis
Published on: January 7, 2019
11.4K
手术前用循环氧化酶-2 抑制剂进行口服治疗,用于囊炎的腺状囊炎
Masato Yanagi1, Norio Motoda2, Akifumi Katsu1
1Department of Urology Nippon Medical School Musashikosugi Hospital Kawasaki Kanagawa Japan.
IJU case reports
|July 5, 2024
概括
在手术前使用循环氧化酶-2 (COX-2) 抑制剂显著降低了囊炎腺瘤体积. 这种治疗策略改善了患者的症状,并促进了手术切除.
科学领域:
- 泌尿器科 泌尿器科 泌尿器科 泌尿器科
- 在瘤学瘤学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 囊炎是膀的一个前发性疾病.
- 之前的研究表明,循环氧化酶-2 (COX-2) 抑制剂可以预防术后复发.
- 在手术前,COX-2 抑制剂在减少瘤体积方面的疗效在很大程度上仍未被探索.
研究的目的:
- 为了研究手术前口服环氧化原酶-2 抑制剂的疗效,减少瘤体积在一个病人囊膜炎.
主要方法:
- 一名45岁的男性患者患有腺囊炎的症状,他接受了囊镜检查,发现了大量的膀质量.
- 患者接受了循环氧化原酶-2 抑制剂口服.
- 瘤体积,尿路孔透度和空洞症状在六周治疗后被评估.
主要成果:
- 口服环氧化原酶-2 抑制剂的使用导致囊炎腺瘤体积显著减少.
- 双边尿道孔变得可识别,阻塞症状得到解决.
- 病理学检查证实了通过尿道切除残留瘤后的肠类囊炎.
结论:
- 在手术前的循环氧化原酶-2抑制表明,在囊炎中,显著减少了瘤体积.
- 这种治疗策略可能有利于治疗腺囊炎,特别是在最终手术治疗之前减少瘤负担.
相关概念视频
Peptic Ulcer Disease IV: Management
85
Medical treatment strategies for peptic ulcers encompass various methods. The primary goal of treatment is to diminish gastric acidity and strengthen mucosal defense mechanisms.
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
85
Drugs for Peptic Ulcer Disease: Prostaglandin Analogs as Mucosal Protective Agents
395
The gastric mucosa produces prostaglandins E2 (PGE2) and prostacyclin (PGI2), crucial in maintaining gastric health. They exert cytoprotective effects, including increasing bicarbonate secretion, releasing protective mucin, reducing gastric acid output, and preventing harmful vasoconstriction. These effects are mediated through various receptors, such as EP1, EP2, EP3, and EP4.
Non-steroidal anti-inflammatory drugs (NSAIDs) can induce peptic ulcers by inhibiting cyclooxygenase, decreasing...
Non-steroidal anti-inflammatory drugs (NSAIDs) can induce peptic ulcers by inhibiting cyclooxygenase, decreasing...
395
Drugs for Treatment of Constipation-Predominant IBS
154
Pharmacological therapies for IBS-C are designed to alleviate abdominal discomfort and enhance bowel function. In patients with IBS-C, fiber supplements may help soften stools and decrease straining, but may also lead to increased gas production and bloating. Osmotic laxatives like milk of magnesia are frequently used to soften stools and increase stool frequency in IBS-C patients. In addition, two drugs approved for use in severe IBS-C adult cases are linaclotide (Linzess) and lubiprostone...
154
Drugs for Treatment of Ulcerative Colitis in IBD
134
Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide...
134
Tonsillitis II: Management
107
This lesson will focus on the different treatment options for managing tonsillitis, which typically depend on the cause and severity.
107
Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy
348
Helicobacter pylori, a resilient gram-negative bacterium, can thrive in the stomach's harsh, acidic environment. Infection with H. pylori leads to a cascade of events within the stomach lining. One of the critical disruptions caused by this bacterium is the interference with somatostatin production, a hormone responsible for regulating acid secretion. This interference tips the balance, escalating acid secretion and diminishing bicarbonate levels. This imbalance compromises the defensive...
348
